Advaxis Inc.

Advaxis Inc.
Stock Exchange Frankfurt Stock Exchange
EPS
-
Market Cap
-
Shares Outstanding
52.83 M
Public Float
41.4 M
Advaxis Inc.
Stock Exchange NASDAQ Stock Market
EPS
$7.26
Market Cap
$14.36 M
Shares Outstanding
8.01 M
Public Float
64.28 M

Profile

Address
305 College Road East
Princeton New Jersey 08540
United States
Employees -
Website http://www.advaxis.com
Updated 07/08/2019
Advaxis, Inc. is a biotechnology company, which engages in the discovery, development, and commercialization of cancer immunotherapies. It manages platform technology that utilizes live attenuated Listeria monocytogenes bioengineered to secrete antigen or adjuvant fusion proteins. It has four franchises in various stages of clinical and pre-clinical development, namely: HPV-associated cancers, prostate cancer, neoantigen therapy, and hotspot mutation therapy.

Financials

View All
Created with Highcharts 5.0.14Advaxis Inc.Net Income. Fiscal year is November-October. All values USD Thousands.19 98619 98616 52516 52547 03147 03173 55673 55693 43593 43566 51566 515201320142015201620172018025k50k75k100k
Created with Highcharts 5.0.14Advaxis Inc.Sales/Revenue. Fiscal year is November-October. All values USD Thousands.001 0001 000003 9943 99412 03112 0316 0636 06320132014201520162017201802.5k5k7.5k10k12.5k15k

David Sidransky
Chairman
Kenneth A. Berlin
President, Chief Executive Officer & Director